Skip to main navigation Skip to search Skip to main content

Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors

  • Eunji Hong
  • , Wojciech Barczak
  • , Sujin Park
  • , Jin Sun Heo
  • , Akira Ooshima
  • , Shonagh Munro
  • , Chang Pyo Hong
  • , Jinah Park
  • , Haein An
  • , Joon Oh Park
  • , Seok Hee Park
  • , Nick B. La Thangue
  • , Seong Jin Kim
  • GILO Foundation
  • Sungkyunkwan University
  • University of Oxford
  • Argonaut Therapeutics Ltd
  • Ltd.
  • Medpacto Inc.

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science